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Abstract
Background: Hemorrhage in the spinal canal leads to further damage of the spinal cord influencing outcome in
dogs with intervertebral disk (IVD) extrusion. The aim of the study was to evaluate blood degradation products and
ferritin in the cerebrospinal fluid (CSF) of dogs with thoracolumbar IVD extrusion, and their association to clinical
parameters and MRI findings.
Results: In the CSF of dogs with IVD extrusion, both net oxyhemoglobin absorption (NOA) and net bilirubin
absorption (NBA) were significantly higher compared to the control groups of dogs with steroid responsive
meningitis arteritis (SRMA) and idiopathic epilepsy (IE) (P < 0.001), but NOA compared to the idiopathic epilepsy
group contaminated artificially with blood (IEc) was not (P = 0.890). Ferritin concentration was significantly higher in
dogs with IVD extrusion compared to dogs with IE (P = 0.034), but not to dogs with SRMA (P = 0.526). There was
no association between NOA, NBA or ferritin concentration and severity or duration of clinical signs. In dogs with a
higher ferritin concentration the outcome was better (P = 0.018). In dogs with evidence of hemorrhage on MRI,
NOA and NBA were significantly higher (P = 0.016, P = 0.009), but not ferritin (P = 0.0628).
Conclusion and clinical importance: Quantification of blood degradation products and ferritin in the CSF of dogs
to assess subarachnoidal hemorrhage is feasible; however, larger case numbers are needed to evaluate the
relevance of NBA and ferritin as prognostic indicators.
Keywords: Spinal cord injury, Oxyhemoglobin, Bilirubin, Subarachnoidal hemorrhage
Background
In paraplegic dogs with thoracolumbar intervertebral
disk (IVD) extrusion, the presence or absence of noci-
ception is considered the most important indicator to
determine the prognosis [1, 2], and generally correlates
with histopathological findings [3]. However, the out-
come of surgically treated paraplegic dogs with absent
nociception varies widely [2, 4–6]. is highlights the fact
that other factors beyond this contribute to recovery or
lack thereof. Several other prognostic factors were previ-
ously studied including severity and duration of clinical
signs, site of disk extrusion, specific magnetic resonance
imaging (MRI) findings [7–9], and cerebrospinal fluid
(CSF) characteristics [10–17].
After the primary mechanical insult on the spinal cord
in IVD extrusion, secondary mechanisms of injury in-
cluding decreased vascular perfusion followed by ische-
mia and perivascular edema, electrolyte imbalances,
glutamatergic excitotoxicity, oxidative stress, inflamma-
tion, and apoptosis lead to further damage of the spinal
cord parenchyma [18, 19]. Additionally, there is strong
evidence that intramedullary and subdural hemorrhage
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has an important impact on the development of second-
ary injury and outcome [20, 21]. Therefore, monitoring
hemorrhage in the subarachnoidal space would seem
useful to assess spinal cord injury (SCI) and hence
prognosis.
Following hemorrhage into the subarachnoidal space,
rapid lysis of red blood cells occurs, thereby releasing
oxyhemoglobin. The liberated oxyhemoglobin is grad-
ually converted into bilirubin and free iron by macro-
phages and other cells of the leptomeninges [22]. The
free iron is detoxified by ferritin [23, 24].
Detection of such products in CSF with spectropho-
tometry for net oxyhemoglobin absorption (NOA) and
net bilirubin absorption (NBA) as well as detection of
ferritin in the CSF is used in people with subarachnoidal
hemorrhage (SAH) when computed tomography of the
head is negative for hemorrhage [24, 27, 28]. Spectro-
photometry for blood degradation products in the CSF
of animals has been used experimentally in a model for
human SAH [28, 29], but to our knowledge, never before
to detect blood degradation products in the CSF in a
naturally occurring disease. Neither have these tech-
niques been used before to assess SCI.
The aim of the present pilot study was to investigate
the utility of spectrophotometry and ferritin ELISA to
quantify blood degradation products and ferritin in CSF
of dogs with SCI following IVD extrusion. Further, we
wanted to assess whether these degradation products
and ferritin are correlated with neurological grade of af-
fected dogs and their outcome, and whether they can be
used as prognostic indicators. We hypothesized that
quantification of blood degradation products and ferritin
in the CSF could be a method to assess subdural
hemorrhage and may serve as useful prognostic indica-
tor because of its influence on secondary damage of the
spinal cord [3, 20, 21, 25, 26]. Additionally, the correl-
ation of blood degradation products and ferritin with
MRI findings was evaluated.
Results
Clinical data
The study population consisted of 58 purebred dogs (33
different breeds), and 11 mixed-bred dogs. Pure breeds
represented by more than three dogs were dachshunds
(n = 10) and French bulldogs (n = 7). Forty-eight dogs
were male (21 castrated), and 21 were female (13
spayed). The mean age of the dogs was 4.8 years (range,
6 months to 12.8 years). The median body weight of the
dogs was 13.5 kg (range, 3.4 to 81.0 kg).
In dogs with IVD extrusion, the initial neurological
condition was Grade I in 1 dog, Grade II in 12, Grade
III in 9, Grade IV in 14, and Grade V in 3 dogs.
The median duration of the clinical signs until CSF
tap was 2 days (range, 1 to 21 days), and the clinical
signs were classified as acute in 20 dogs, subacute in 13
dogs, and chronic in 6 dogs, accordingly. Three of the
chronically affected dogs displayed a worsening of clin-
ical signs within the last 24 h.
The IVD extrusion site was at T11-T12 in three dogs,
T12-T13 in 13 dogs, T13-L1 in 12 dogs, L1-L2 in one
dog, L2-L3 in four dogs, L3-L4 in two dogs, L4-L5 in
three dogs, and L5-L6 in one dog. Time of discharge or
euthanasia was between 0 and 17 days (median 4). Thirty
dogs had a good outcome and were ambulatory, one dog
showed an improvement, but was not ambulatory at
time of discharge. The remaining 8 dogs were eutha-
nized immediately after imaging (n = 2 of each; neuro-
logical grade IV and V), after detoriation of neurological
signs (n = 3; neurological grade II to III, grade II to V,
and grade IV to V), and because of lack of improvement
(n = 1, neurological grade IV).
Magnetic resonance imaging
On MRI, hemorrhage was evident in 24 dogs, whereas
in the 15 remaining dogs no signs of hemorrhage were
visible.
Serum bilirubin levels and cerebrospinal fluid analysis
Median values and ranges of serum bilirubin, CSF total
protein, WBC count, NBA, NOA, and ferritin concen-
tration, results of pandy testing and CSF cytology, and
the classification according to Cruickshank et al. of the
different groups are given in Table 1.
Spectrophotometric analysis of NOA and NBA has
been performed in 33 of 39 dogs with IVD extrusion,
and routine CSF analysis in 6 of these 33 dogs because
of insufficient quantity of CSF.
Statistical analysis
Comparing the IE and IEc group, NOA was significantly
higher in the IEc group (P < 0.001), and NBA and ferritin
concentration were not different between both groups
(P = 0.272, P = 0.546, respectively). (Fig. 1a-c).
The NOA and NBA were significantly higher in the CSF
of dogs with IVD extrusion compared to dogs with IE
(both P < 0.001) and SRMA (both P < 0.001). (Fig. 2a, b).
The CSF ferritin concentration was significantly higher
in dogs with IVD extrusion compared to dogs with IE (P
= 0.034), but not to dogs with SRMA (P = 0.526). (Fig. 2c).
Using the classification according to Cruickshank et al.
[27] (Fig. 4), dogs with IVD extrusion showed signifi-
cantly more often hemorrhage in the subarachnoidal
space than dogs with IE and SRMA (both P < 0.001).
Comparing the non-contaminated and contaminated
CSF of the IE dogs according to this classification, the
IEc showed significantly more often hemorrhage in the
subarachnoidal space than the IE (P = 0.002).
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In dogs with IVD extrusion, there was no association be-
tween NOA, NBA, or ferritin concentration and the initial
neurological grade (P = 0.104, P = 0.081, P = 0.704, respect-
ively), and duration of clinical signs (P = 0.411, P = 0.218, P
= 0.663, respectively). There was also no association be-
tween NOA or NBA and the outcome (P = 0.967, P = 0.310,
respectively), but dogs with a higher ferritin concentration
in the CSF had a better outcome (P = 0.018).
Using the classification according to Cruickshank et al.
there was no association to the outcome (P = 0.733).
In dogs with evidence of hemorrhage on MRI, there was
a significantly higher NOA and NBA (P = 0.016, P = 0.009,
respectively), but no association with ferritin (P = 0.628).
Discussion
We have shown before that hemorrhage in SCI is associ-
ated with the severity of white and gray matter damage
and the longitudinal extension of myelomalacia [21]. In
addition to the mechanical effects of hemorrhagic cord
necrosis [21], it has been a long held view that disruption
of the blood-spinal cord barrier with hemorrhage follow-
ing SCI leads to exposure of the myelon to destructive ef-
fects of, among others, cytotoxic neurotransmitters [35],
cytokines [36], vasoactive peptides [37], oxygen free radi-
cals [38], endothelin-1 [26, 39, 40] and heme-oxygenase-1
[41]. We hypothesized that detection of blood degradation
products in the CSF could be a promising prognostic indi-
cator [21]. A major challenge is to distinguish intra vitam
from iatrogenic hemorrhage resulting from CSF puncture.
Indeed as reported in people and dogs previously [42, 43],
the latter was often suspected since we used lumbar punc-
ture in view of the scope of this study. Counting erythro-
cytes or measuring hemoglobin cannot be used to
distinguish between iatrogenic and true hemorrhage [44].
Table 1 Median values and ranges of serum bilirubin levels, cerebrospinal fluid analysis, spectrophotometric and ferritin measurements
Intervertebral disc extrusion Idiopathic epilepsy Idiopathic epilepsy contaminated Steroid-responsive meningitis-arteritis
(n = 39) (n = 21) (n = 21) (n = 9)
Routine CSF analysis
WBC / μl *
median (range) 8 (1–14) 0.67 (0–5) 47.67 (66–1680)
TP (g/l) *
median (range) 0.73 (0.14–8.55) 0.12 (0.11–0.23) 0.25 (0.15–0.8)
Pandy (number) *
– 2 17 5
+ 3 4 4
++
+++ 1
Cytology (number)
mononuclear 2 1
neutrophilic 1 8
CSF spectrophotometry
NOA (AU) **
median (range) 0.073 (0–3.585) 0.002 (0–0.009) 0.064 (0.003–1.505) 0.004 (0–0.010)
NBA (AU) **
median (range) 0.016 (0–0.373) 0.001 (0–0.007) 0.001 (0–0.011) 0.002 (0.001–0.008)
ELISA CSF Ferritin (ng/ml)
median (range) 41.28 (15.08–228.19) 33.90 (13.58–64.00) 36.73 (15.00–653.30) 31.11 (17.84–125.14)
Serum Bilirubin (μmol/l)
median (range) 2 (0.7–6) 2 (0.7–6) 2 (1–4.2)
Classification of the result according to Cruickshank [27]
Subarachnoidal hemorrhage:
yes 26 0 1 1
no 6 21 13 8
not excluded 1 0 7 0
*performed in 6 dogs,** performed in 33 dogs, WBC, white blood cell count; TP, total protein; AU, absorption units; NOA, net oxyhemoglobin absorption; NBA net
bilirubin absorption; CSF, cerebrospinal fluid
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Fig. 1 Comparison of (a) net oxyhemoglobin absorbance (NOA) (b)
net bilirubin absorbance (NBA), and (c) ferritin concentration in the
cerebrospinal fluid (CSF) of dogs with idiopathic epilepsy either
non-contaminated (IE) or artificially blood contaminated (IEc). The box
represents the 25th, 50th, and 75th percentile of the distribution; the
whiskers approximate the 5th–95th percentile; * indicates values of P<0.05
Fig. 2 Comparison of (a) net oxyhemoglobin absorbance (NOA), (b)
net bilirubin absorbance (NBA), and (c) ferritin concentration in the
cerebrospinal fluid (CSF) of dogs with intervertebral disc extrusion
(IVDE) to dogs with idiopathic epilepsy (IE) and dogs with steroid
responsive meningitis arteritis (SRMA). The box represents the 25th,
50th, and 75th percentile of the distribution; the whiskers
approximate the 5th–95th percentile; * indicates values of P < 0.05
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Detection of erythrophages and siderophages in the CSF
can provide information about the age and dynamics of
the bleeding, however, studies in the human literature in-
cluded too few patients to estimate sensitivity for SAH
[44, 45]. Spectrophotometry of CSF for bilirubin and oxy-
hemoglobin is recommended by the British national
guidelines in human patients with suspected SAH when
computed tomography is negative in order to determine
the need for angiography [27]. Spectrophotometry has an
estimated sensitivity of 87–100% and specificity of 75–
99% for aneurysmal SAH in human patients [31, 46–48].
Bilirubin in CSF may serve as an indicator of central ner-
vous system hemorrhage but only in the absence of severe
blood-CSF barrier breakdown, and jaundice [27, 42].
Hence, a decision tree which takes the NOA, NBA, serum
bilirubin and CSF protein concentration into consider-
ation is recommended in the British national guidelines to
interpret spectrophotometric results from human patients
[27]. In the present study, we found that the same decision
tree could be used for the assessment of spinal cord
hemorrhage in dogs, with the limitation of traumatic
puncture.
Following hemorrhage into the subarachnoidal space,
rapid lysis of red blood cells occurs within two to four
hours as a consequence of the low CSF osmolarity lead-
ing to release of oxyhemoglobin, which may be detected
between two and 12 h up to one week after the onset of
bleeding [44]. However, oxyhemoglobin can also result
from in vitro hemolysis after a traumatic puncture [43].
Accordingly, in the present study, NOA was signifi-
cantly higher following artificial blood contamination of
the CSF and subsequent centrifugation within 15 min
compared to the same CSF without contamination.
Therefore, NOA has a relatively high probability of
falsely elevated results especially in lumbar CSF taps due
to traumatic puncture in the face of iatrogenic blood
contamination, and thus rendering the interpretation of
significantly elevated NOA in dogs with IVD extrusion
difficult. We concluded that NOA may be of limited
value to assess cord hemorrhage.
The liberated oxyhemoglobin is gradually converted into
bilirubin and free iron by macrophages and other cells of
the leptomeninges [22]. Thus, an elevation of bilirubin
cannot be explained by a traumatic puncture, as reflected
by the NBA results clearly distinguishing between artifi-
cially blood contaminated and non-contaminated CSF of
IE dogs. The conversion into bilirubin and iron is detect-
able about 12 h after onset of hemorrhage [27, 29], in-
creases over approximately one week, and remains
detectable for two to four weeks after the hemorrhage in
people [22, 31]. In the present study, all CSF taps were
performed after more than 12 h and less than 3 weeks
after the beginning of clinical symptoms, and we could
show a significant elevation of NBA in dogs with SCI
compared to controls. However, we could not find a cor-
relation between NBA values and initial neurological
grade, duration of clinical signs and outcome in dogs with
IVD extrusion which may be due to several variables. The
level of bilirubin in the CSF is not only dependent on the
quantity of hemorrhage, but also very much on the time
point of CSF puncture after SCI, and hence the conversion
stage of oxyhemoglobin. The interpretation of NBA values
may be further complicated by progression of the IVD dis-
ease. For example, in the present study, three of six chron-
ically affected dogs showed an acute worsening of clinical
signs possibly by further extrusion of IVD material [49–
51] perhaps leading to new hemorrhage. Beside the stage
of hemorrhage, the distance of the primary lesion site to
the site of CSF tap could also have an influence on the re-
sults. In the present study, the CSF tap was performed at
L5–6 or L6–7 and the distance to the IVD extrusion site
was between zero and seven vertebral bodies.
Ferritin is the main extra-cellular iron transporter, and
located in every organ. After hemorrhagic events, it is
synthesized by several cell types among others macro-
phages in order to bind free iron, and to prevent the oc-
currence of free radicals that damage tissues [52]. The
free iron gets detoxified by ferritin which reaches a max-
imum peak after about eight to 11 days following
hemorrhage [23, 24]. The ferritin concentration was sig-
nificantly higher in the CSF of dogs with IVD extrusion
compared to dogs with IE, but not compared to dogs
with SRMA. The latter is consistent with previous obser-
vations according to which ferritin concentration in the
CSF is also increased in inflammation of the central ner-
vous system, especially in pyogenic inflammation [52].
Interestingly, dogs who recovered ambulation had a sig-
nificantly higher ferritin concentration than dogs with a
poor outcome. However, in addition to hemorrhage as a
source of iron, the ferritin concentration could also reflect
the inflammatory response following SCI, which is ex-
tremely complex and has both beneficial and deleterious
effect [53–56]. In the spinal cord, ferritin is a marker of
microglia, which is important for reestablishing tissue
homeostasis after SCI [55, 57–59]. However, the interpret-
ation of ferritin levels in canine CSF was also complicated
by its wide concentration range in the control dogs. It
normally does not cross the blood brain barrier due to its
relative high molecular weight of 450 kD [60], and no cor-
relation between CSF and serum ferritin concentration
has been found in people. The upper normal range of fer-
ritin in human CSF is 12 ng/ml. The level of ferritin in the
CSF of control dogs with IE in the present study was be-
tween 13 and 64 ng/ml. However, to evaluate the normal
range of ferritin in the CSF of dogs, a larger case number
of completely healthy dogs should be examined.
MRI is the method of choice to evaluate the spinal canal
for the presence of hemorrhage until now. However, to
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distinguish between extradural and subdural hemorrhage,
and especially its quantification remains difficult. The
amount of blood degradation products in the CSF corre-
lated with the evidence of hemorrhage on MRI in the
present study.
Limitations of the present pilot study are the very low
number of paraplegic dogs with loss of nociception and
the short follow up time of dogs with a poor outcome
probably leading to biased statistical results. Additionally
the variation in clinical duration (acute vs. acute on
chronic vs. chronic) may have affected the measurements.
Larger case numbers are needed. Also intraparenchymal
hemorrhage is most likely missed with measurements of
blood degradation products in the CSF.
Conclusion
The results of this study show that detection of blood
degradation products such as oxyhemoglobin, bilirubin
and ferritin in lumbar CSF to demonstrate hemorrhage
in the subarachnoidal space of dogs following IVD ex-
trusion is feasible, and correlates with MRI findings.
However, while significant differences were found be-
tween dogs with IVD disease and controls, correlations
of NOA and NBA to the initial neurological grade and
the outcome in individual animals could not be found.
NOA is not recommended after a lumbar CSF puncture
due to the high risk of iatrogenic blood contamination.
Paradoxically, dogs who regained ambulation had signifi-
cantly higher CSF ferritin concentration.
Since the generation of blood degradation products in
the CSF is a highly dynamic process bilirubin and ferritin
values depend very strongly on the duration of clinical
signs. Larger numbers of animals for each defined point in
time following initial SCI are necessary to evaluate the use-
fulness of bilirubin and ferritin as prognostic indicators.
Methods
Case selection
Examination of the CSF for blood degradation products was
performed prospectively in 39 dogs with thoracolumbar IVD
extrusion which were presented between September 2013
and October 2015 at the veterinary teaching hospital of the
University of Bern. Inclusion criteria were diagnosis of surgi-
cally or histopathologically confirmed thoracolumbar IVD
extrusion, well-documented clinical records (breed, age, gen-
der, duration of clinical signs, neurological grade, MRI find-
ings, outcome), and sufficient quantity of CSF (0.5ml) for
measurements. Additionally, CSF of 21 dogs with idiopathic
epilepsy (IE) and 9 dogs with steroid responsive meningitis
arteritis (SRMA) served as controls.
Clinical data
Breed, age and gender of all dogs were recorded, and a
complete neurological examination was performed at
the time of presentation. In dogs with thoracolumbar
IVD extrusion, duration and severity of clinical signs,
site of IVD extrusion, and outcome were noted.
The initial neurological condition was graded on a I to V
scale as published before [3]: Grade I, spinal hyperesthesia
only; Grade II, ambulatory paraparesis, ataxia, and proprio-
ceptive deficits; Grade III, non-ambulatory paraparesis;
Grade IV, paraplegia with present nociception; and Grade
V, paraplegia with loss of nociception. In case of grade dif-
ferences between left and right limbs, the more severe
grade was assigned.
Duration of neurologic signs was defined as the time
between the first observed clinical signs and collection
of CSF, and was grouped as follows: CSF collection
within the first 48 h (acute), within 2–7 days (subacute),
or after more than 7 days (chronic) according to previ-
ous studies [30].
In all included dogs with thoracolumbar IVD extru-
sion, the diagnosis was provided by MRI and confirmed
during standard hemilaminectomy.
The neurological condition was reevaluated at time of
discharge. The outcome was determined as follows:
grade 0 - lack of improvement or euthanasia; grade 1 -
improvement of the neurological status by at least one
grade, but not able to walk without support; grade 2 -
recovery to ambulation [20].
In control dogs, the diagnosis of IE or SRMA was
based on signalement, history, clinical signs and specific
diagnostic testing. Dogs with IE displayed no interictal
neurological deficits, metabolic causes were excluded,
and MRI of the head and CSF tap were unremarkable.
Dogs with SRMA revealed suspicious clinical signs (neck
pain, pyrexia), a CSF tap with neutrophilic pleocytosis
and without detectable pathologic organisms on cy-
tology, an increased immunoglobulin A level in serum
and CSF, and a resolution of clinical signs after treat-
ment with corticosteroids.
Magnetic resonance imaging
MRI examinations were performed in all dogs using a
1.0-T magnet 1. The MRI protocol usually included a
transverse and sagittal T2-weighted fast spin-echo se-
quence, a sagittal fluid-attenuating inversion recovery se-
quence (FLAIR), a dorsal short tau inversion recovery
sequence (STIR), dorsal and transverse T1-weighted se-
quences, and a transverse T2*-weighted sequence.
Board-certified radiologists qualitatively evaluated the
MRI images and judged hemorrhage in the spinal canal
(epidural, subdural) as present or not present.
Serum bilirubin levels and cerebrospinal fluid analysis
A blood sample of all dogs was taken by venipuncture at
the time of CSF collection, and serum bilirubin levels
were determined [31].
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For the measurements of blood degradation products
and ferritin, a minimum of 0.5 ml CSF was needed. The
CSF tap was performed under general anesthesia at the
cisterna magna in dogs with SRMA, and subsequently
following MRI in dogs with IE. A lumbar tap (L5–6 or
L6–7) was performed following MRI in dogs with thora-
columbar IVD extrusion.
In dogs with IVD extrusion, 0.5 ml of the CSF was proc-
essed immediately for measurements of blood degradation
products (see below), and if provided that a sufficient
quantity of CSF remained, routine CSF analysis was per-
formed including white blood cell (WBC) count, total pro-
tein, pandy testing, and in cases with a WBC count > 5 /
microliter cytology following cytospin preparation.
To evaluate the potential effect of blood contamin-
ation during CSF puncture on spectrophotometric and
ferritin measurements, the CSF samples from the 21
dogs with IE were divided in two parts (each at least 0.5
ml), and one part was artificially contaminated with a
drop of blood (IEc).
All CSF samples, were protected from light immediately
after collection, centrifuged (10min, 2360 g, 4 °C) within
15min, and the supernatant stored in Eppendorf-tubes at
− 20 °C until further diagnostics [27, 32, 33]. The samples
were analyzed at wave lengths between 350 and 660 nm
using a Shimadzu UV-1800 spectrophotometer 2 in the
Center of Laboratory Medicine, University Institute of Clin-
ical Chemistry (Inselspital). NOA and NBA were deter-
mined in the CSF according the Chalmers’ calculation [34].
A predicted baseline, which forms a tangent to the scan be-
tween 350 and 400 nm and again between 430 and 530 nm
was drawn. The absorbance above this predicted baseline at
476 nm reflects the NBA. If the baseline forms a tangent to
the scan before 476 nm, the measured NBA is by definition
zero. The NOA is represented by any oxyhemoglobin peak
above this predicted baseline (Fig. 3) [27].
Additionally, the measurements were interpreted in re-
spect to the serum bilirubin and CSF total protein level
by following a recommended decision tree [27]: (1) no
evidence of SAH, or (2) consistent with SAH, or (3)
SAH cannot be excluded (Fig. 4).
Ferritin was determined quantitatively in the CSF using
a commercially available canine ferritin ELISA kit 3. Every
sample was measured in duplicates. Subsequently; the
mean was calculated and used for statistical evaluation.
Statistical analysis
Dogs were assigned to one of the following four groups:
(1) dogs with thoracolumbar IVD extrusion, (2) dogs
with IE, (3) dogs with IE and CSF artificially blood con-
taminated (IEc), and (4) dogs with SRMA.
For statistical analysis, the neurological grade of dogs
with IVD extrusion at the initial presentation was
classed together to ambulatory paraparesis (grade I, II),
non-ambulatory paraparesis (grade III), and paraplegia
(grade IV, V). Due to small case numbers, the outcome
grades 0 and 1 were merged.
Statistical evaluation was performed using the software
package NCSS 9 (http://www.ncss.com). The threshold
value for statistical significance was set at P < 0.05.
Since data were not normally distributed
non-parametric tests were used. The Kruskal-Wallis test
was used to evaluate the equality of variance for NOA,
NBA, ferritin, and the classification according to Cruick-
shank et al. [27]. Multiple comparisons between dogs with
IVD extrusion and the control dogs with IE or SRMA
were performed using the Kruskal-Wallis test and the
Wilcoxon two-sample test, respectively. The influence of
iatrogenic blood contamination was evaluated by compar-
ing NOA, NBA, ferritin concentration, and the classifica-
tion according to Cruickshank et al. [27] between the IE
and IEc group using the Wilcoxon two-sample test.
Fig. 3 Representative spectrophotometric scan (blue curve). A predicted baseline (black), which forms a tangent to the scan between 350 and
400 nm and between 430 and 530 nm was drawn. The vertical reference line at 476 nm represents the net bilirubin absorbance (green), and the
vertical reference line at any peak between 410 and 418 nm the net oxyhemoglobin absorbance (red)
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In dogs with thoracolumbar IVD extrusion, associa-
tions between NOA, NBA, ferritin, and the classification
according to Cruickshank et al. [27] in the CSF and (1)
the initial neurological grade, (2) the duration of clinical
signs, (3) the outcome, and (4) MRI findings were statis-
tically evaluated using the Kruskal-Wallis test and the
Wilcoxon two-sample test, respectively. Results are given
as median and range (5th–95th percentile).
Endnotes
1Panorama HFO, Philips Medical Systems
2UV/VIS spectrophotometer Shimadzu UV-1800,
Shimadzu, Kyoto, Japan
3Canine ferritin ELISA kit, BlueGene Biotech, Putuo
District, Shanghai, China
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